FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116996913> ?p ?o ?g. }

• W2116996913 endingPage "1756" @default.
• W2116996913 startingPage "1748" @default.
• W2116996913 abstract "A dosage formula has been derived from a retrospective analysis of carboplatin pharmacokinetics in 18 patients with pretreatment glomerular filtration rates (GFR) in the range of 33 to 136 mL/min. Carboplatin plasma clearance was linearly related to GFR (r = 0.85, P less than .00001) and rearrangements of the equation describing the correlation gave the dosage formula dose (mg) = target area under the free carboplatin plasma concentration versus time curve (AUC) x (1.2 x GFR + 20). In a prospective clinical and pharmacokinetic study the formula was used to determine the dose required to treat 31 patients (GFR range, 33 to 135 mL/min) with 40 courses of carboplatin. The target AUC was escalated from 3 to 8 mg carboplatin/mL/min. Over this AUC range the formula accurately predicted the observed AUC (observed/predicted ratio 1.24 +/- 0.11, r = 0.886) and using these additional data, the formula was refined. Dose (mg) = target AUC x (GFR + 25) is now the recommended formula. AUC values of 4 to 6 and 6 to 8 mg/mL. min gave rise to manageable hematological toxicity in previously treated and untreated patients, respectively, and hence target AUC values of 5 and 7 mg/mL min are recommended for single-agent carboplatin in these patient groups. Pharmacokinetic modeling demonstrated that the formula was reasonably accurate regardless of whether a one- or two-compartment model most accurately described carboplatin pharmacokinetics, assuming that body size did not influence nonrenal clearance. The validity of this assumption was demonstrated in 13 patients where no correlation between surface area and nonrenal clearance was found (r = .31, P = .30). Therefore, the formula provides a simple and consistent method of determining carboplatin dose in adults. Since the measure of carboplatin exposure in the formula is AUC, and not toxicity, it will not be influenced by previous or concurrent myelosuppressive therapy or supportive measures. The formula is therefore applicable to combination and high-dose studies as well as conventional single-agent therapy, although the target AUC for carboplatin will need to be redefined for combination chemotherapy." @default.
• W2116996913 created "2016-06-24" @default.
• W2116996913 creator A5006879181 @default.
• W2116996913 creator A5007986153 @default.
• W2116996913 creator A5013174494 @default.
• W2116996913 creator A5023959739 @default.
• W2116996913 creator A5031760532 @default.
• W2116996913 creator A5037778274 @default.
• W2116996913 creator A5047317647 @default.
• W2116996913 creator A5053304892 @default.
• W2116996913 creator A5063293745 @default.
• W2116996913 creator A5081548327 @default.
• W2116996913 date "1989-11-01" @default.
• W2116996913 modified "2023-10-09" @default.
• W2116996913 title "Carboplatin dosage: prospective evaluation of a simple formula based on renal function." @default.
• W2116996913 cites W125318081 @default.
• W2116996913 cites W1494743832 @default.
• W2116996913 cites W1534631834 @default.
• W2116996913 cites W1592463148 @default.
• W2116996913 cites W1727163805 @default.
• W2116996913 cites W1733542310 @default.
• W2116996913 cites W1764040454 @default.
• W2116996913 cites W1818464951 @default.
• W2116996913 cites W1898544704 @default.
• W2116996913 cites W1959295051 @default.
• W2116996913 cites W1968469810 @default.
• W2116996913 cites W1972659786 @default.
• W2116996913 cites W1980543942 @default.
• W2116996913 cites W1986914074 @default.
• W2116996913 cites W2002314919 @default.
• W2116996913 cites W2013093345 @default.
• W2116996913 cites W2022216238 @default.
• W2116996913 cites W2028940434 @default.
• W2116996913 cites W2030471493 @default.
• W2116996913 cites W2044640058 @default.
• W2116996913 cites W2052410864 @default.
• W2116996913 cites W2053495438 @default.
• W2116996913 cites W2056327372 @default.
• W2116996913 cites W2067593296 @default.
• W2116996913 cites W2070751105 @default.
• W2116996913 cites W2072600131 @default.
• W2116996913 cites W2075817798 @default.
• W2116996913 cites W2091455299 @default.
• W2116996913 cites W2091995329 @default.
• W2116996913 cites W2168129520 @default.
• W2116996913 cites W2265594607 @default.
• W2116996913 cites W2431758486 @default.
• W2116996913 cites W2468707786 @default.
• W2116996913 cites W2887769440 @default.
• W2116996913 doi "https://doi.org/10.1200/jco.1989.7.11.1748" @default.
• W2116996913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2681557" @default.
• W2116996913 hasPublicationYear "1989" @default.
• W2116996913 type Work @default.
• W2116996913 sameAs 2116996913 @default.
• W2116996913 citedByCount "1743" @default.
• W2116996913 countsByYear W21169969132012 @default.
• W2116996913 countsByYear W21169969132013 @default.
• W2116996913 countsByYear W21169969132014 @default.
• W2116996913 countsByYear W21169969132015 @default.
• W2116996913 countsByYear W21169969132016 @default.
• W2116996913 countsByYear W21169969132017 @default.
• W2116996913 countsByYear W21169969132018 @default.
• W2116996913 countsByYear W21169969132019 @default.
• W2116996913 countsByYear W21169969132020 @default.
• W2116996913 countsByYear W21169969132021 @default.
• W2116996913 countsByYear W21169969132022 @default.
• W2116996913 countsByYear W21169969132023 @default.
• W2116996913 crossrefType "journal-article" @default.
• W2116996913 hasAuthorship W2116996913A5006879181 @default.
• W2116996913 hasAuthorship W2116996913A5007986153 @default.
• W2116996913 hasAuthorship W2116996913A5013174494 @default.
• W2116996913 hasAuthorship W2116996913A5023959739 @default.
• W2116996913 hasAuthorship W2116996913A5031760532 @default.
• W2116996913 hasAuthorship W2116996913A5037778274 @default.
• W2116996913 hasAuthorship W2116996913A5047317647 @default.
• W2116996913 hasAuthorship W2116996913A5053304892 @default.
• W2116996913 hasAuthorship W2116996913A5063293745 @default.
• W2116996913 hasAuthorship W2116996913A5081548327 @default.
• W2116996913 hasConcept C112705442 @default.
• W2116996913 hasConcept C126322002 @default.
• W2116996913 hasConcept C126894567 @default.
• W2116996913 hasConcept C159641895 @default.
• W2116996913 hasConcept C2776694085 @default.
• W2116996913 hasConcept C2778239845 @default.
• W2116996913 hasConcept C2781451048 @default.
• W2116996913 hasConcept C71924100 @default.
• W2116996913 hasConcept C76318530 @default.
• W2116996913 hasConcept C98274493 @default.
• W2116996913 hasConceptScore W2116996913C112705442 @default.
• W2116996913 hasConceptScore W2116996913C126322002 @default.
• W2116996913 hasConceptScore W2116996913C126894567 @default.
• W2116996913 hasConceptScore W2116996913C159641895 @default.
• W2116996913 hasConceptScore W2116996913C2776694085 @default.
• W2116996913 hasConceptScore W2116996913C2778239845 @default.
• W2116996913 hasConceptScore W2116996913C2781451048 @default.
• W2116996913 hasConceptScore W2116996913C71924100 @default.
• W2116996913 hasConceptScore W2116996913C76318530 @default.
• W2116996913 hasConceptScore W2116996913C98274493 @default.

• next